SCHEMBL26324924

SCHEMBL26324924

CCCCN(CCc1ccccc1)C(C(=O)OC(C)C)C(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
DRD2 P14416 2/20 0.40
OPRM1 P35372 2/20 0.40
DRD3 P35462 2/20 0.40
OPRD1 P41143 2/20 0.40
OPRK1 P41145 2/20 0.40
THRA P10827 1/20 0.39
THRB P10828 1/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
POLB P06746 1/20 0.39
HSD17B10 Q99714 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CTSK P43235 2/20 0.38
ALOX5 P09917 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20564572 0.87 TSHR (0.43) TSHRHDAC1HDAC6DRD2OPRM1
SCHEMBL26324884 0.84 LMNA (0.42) TSHRALDH1A1LMNACTSK
SCHEMBL26324913 0.80 SIGMAR1 (0.49) TSHRHDAC1HDAC6SIGMAR1
SCHEMBL26325026 0.78 TSHR (0.50) TSHRHDAC1HDAC6ALDH1A1LMNA
SCHEMBL26324920 0.78 TSHR (0.44) TSHRHDAC1HDAC6SIGMAR1
SCHEMBL26324890 0.78 ALDH1A1 (0.39) TSHRALDH1A1LMNAPOLBHSD17B10
SCHEMBL26327722 0.75 DRD2 (0.43) TSHRDRD2OPRM1DRD3OPRD1
SCHEMBL26324888 0.72 ALDH1A1 (0.41) TSHRALDH1A1LMNAPOLBHSD17B10
SCHEMBL25439817 0.72 SIGMAR1 (0.51) TSHRHDAC1HDAC6SIGMAR1
SCHEMBL25440228 0.69 ESR1 (0.41) TSHRALDH1A1LMNAL3MBTL1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents WILLIAM MARSH RICE UNIVERSITY (US) 2023-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents PNMT, NCL, NPM1 TSHR 2716/4885HDAC1 2642/4885HDAC6 894/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.